Position in AMGN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,188,477
+$33,706 QoQ
Shares Held
3,282
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#1,587
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First City Capital Management, Inc. holds $23,745,475 across 11 Drug Manufacturers - General names. AMGN ranks #5 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,107 | $7,324,919 | |
| 2 | ABBV |
AbbVie Inc.
|
24,295 | $6,113,593 | |
| 3 | JNJ |
Johnson & Johnson
|
10,712 | $2,720,526 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,988 | $2,311,458 | |
| 5 | AMGN |
Amgen Inc
This page
|
3,282 | $1,188,477 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,427 | $1,119,383 | |
| 7 | PFE |
Pfizer Inc
|
35,814 | $862,401 | |
| 8 | AZN |
Astrazeneca PLC
|
3,619 | $686,234 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,188,477 | 3,282 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,154,771 | 3,282 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,088,633 | 3,326 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $959,762 | 3,401 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $949,593 | 3,401 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,059,581 | 3,401 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $978,703 | 3,755 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $1,210,220 | 3,756 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,182,935 | 3,786 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,083,543 | 3,811 | Shares | Sole | 2024-05-22 | |
| 2023-12-31 | $1,097,644 | 3,811 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,028,275 | 3,826 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $846,784 | 3,814 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $901,485 | 3,729 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $1,055,024 | 4,017 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $857,421 | 3,804 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $833,059 | 3,424 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $834,037 | 3,449 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $761,073 | 3,383 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $684,307 | 3,218 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $755,137 | 3,098 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $771,311 | 3,100 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $712,292 | 3,098 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,438,799 | 5,661 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $789,187 | 3,346 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $655,831 | 3,235 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||